Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Feb 16:55:e11711.
doi: 10.1590/1414-431X2021e11711. eCollection 2022.

Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age

Affiliations
Meta-Analysis

Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age

J Fabião et al. Braz J Med Biol Res. .

Abstract

We aimed to study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones. To do so, we used age as a covariate in the meta-regression and subgroup analyses. This was a systematic search and meta-analysis of observational cohorts reporting COVID-19 outcomes. The PubMed (Medline) and Cochrane Library databases were searched. The primary outcome was COVID-19-associated mortality and the secondary outcome was COVID-19 severity. The study was registered at PROSPERO: 42020182924. For mortality, men had a relative risk of 1.36 (95%CI: 1.17 to 1.59; I2 63%, P for heterogeneity <0.01) compared to women. Age was not a significant covariate in meta-analysis heterogeneity (P=0.393) or subgroup analysis. For disease severity, being male was associated with a relative risk of 1.29 (95%CI: 1.19 to 1.40; I2 48%, P for heterogeneity <0.01) compared to the relative risk of women. Again, age did not influence the outcomes of the meta-regression (P=0.914) or subgroup analysis. Men had a higher risk of COVID-19 mortality and severity regardless of age, decreasing the odds of hormonal influences in the described outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Study flowchart.
Figure 2
Figure 2. Forest plot for COVID-19 mortality in male patients.
Figure 3
Figure 3. Forest plot for COVID-19 severity in male patients.

References

    1. Jotz GP, Stein A, Sirena S, Barros E, Baldisserotto J, de Figueiredo JAP, et al. The COVID-19 pandemic and planetary health. a critical review of epidemiology, prevention, clinical characteristics and treatments for oral, head and neck health professionals. Do we have a roadmap? Int Arch Otorhinolaryngol. 2020;24:e351–e358. doi: 10.1055/s-0040-1714143. - DOI - PMC - PubMed
    1. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020;3:e205619. doi: 10.1001/jamanetworkopen.2020.5619. - DOI - PMC - PubMed
    1. Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020;92:1759–1760. doi: 10.1002/jmv.25860. - DOI - PMC - PubMed
    1. Giagulli VA, Guastamacchia E, Magrone T, Jirillo E, Lisco G, De Pergola G, et al. Worse progression of COVID‐19 in men: is testosterone a key factor? Andrology. 2021;9:53–64. doi: 10.1111/andr.12836. - DOI - PMC - PubMed
    1. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86:724–731. doi: 10.1210/jcem.86.2.7219. - DOI - PubMed